Zyme Communications News Today

Partnership to develop and implement Cellular Origins' robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult's Stevenage Manufacturing Innovation Centre Cellular

Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens Board Exonate Ltd., a biotechnology company developing novel

Partnership expands spectrum of Secarna's capabilities for the development of targeted ASOs beyond antibodies and sugar molecules New platform capabilities extend the reach of Secarna's antisense

EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): AgreementSecarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics 28.05.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announ...

EXONATE APPOINTS DR RAFIQ HASAN AS NON-EXECUTIVE DIRECTOR Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens

Appointment of digital healthcare leader to Board to support the Company as it enters next phase of commercial development Co-founder and former CEO of Lemonaid Health, a leading innovator

New drug discovery platform integrates computational approaches with molecular biology for development of novel degrader therapeutics PhoreMost Ltd., a leading UK biopharmaceutical company unlocking

License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering ERS Genomics Limited ('ERS'), the CRISPR licensing Company, and IRBM

BioPharma

Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification. Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell